Table 4.
Characteristics of HCC by Surveillance
| Spontaneous | Surveillance | P value | ||||
|---|---|---|---|---|---|---|
| Surveillance | 86 | 53.42% | 75 | 46.58% | ||
| Milan criteria | No | 59 | 68.60% | 33 | 44.59% | 0.002 |
| Yes | 27 | 31.40% | 41 | 55.41% | ||
| Referred for Transplant | No | 67 | 79.76% | 39 | 54.93% | <0.001 |
| Yes | 17 | 20.24% | 32 | 45.07% | ||
| Treatment for HCC | No | 36 | 41.86% | 27 | 36.49% | 0.488 |
| Yes | 50 | 58.14% | 47 | 63.51% | ||
| Initial MELD | Median (IQR) | 12 (6) | 10 (5) | <0.001 | ||
| Final MELD | Median (IQR) | 17 (9) | 15 (12) | <0.001 | ||
Abbreviations: HCC, hepatocellular carcinoma; IQR, interquartile range; MELD, Model for End Stage Liver Disease.